3D Signatures has appointed Jason Flowerday as CEO. He succeeds Ferenc Somogyvari, who will remain on the company's board of directors. Flowerday has more than a decade of business development and marketing experience in the life sciences, including leadership experience at Bayer and Johnson and Johnson. He has also held executive leadership and entrepreneurial roles with Knight Therapeutics and Pro Bono Bio. Additionally, Flowerday was co-founder and co-owner of both Orphan Canada and RxMedia Healthcare Communications, and he is an independent director of Aequus Pharmaceuticals.